Driving Transformation: Interconnected Global Chemicals Logistics
DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.
Interview with Markus Kanis, DP World
DP World is accelerating the transformation of global chemical supply chains, reshaping visibility, predictability, and operational resilience across ports, terminals, and multimodal networks. Under the leadership of Markus Kanis, Global SVP for the Chemicals sector, the company is unifying systems, deploying new technologies, and building real-time decision-making capabilities that offer the chemical industry greater efficiency and risk management. Christene Smith of CHEManager speaks with him about DP World’s strategic roadmap, new technologies, and the evolving demands of global trade.
In which areas - infrastructure, partnerships, modal capabilities - is DP World currently investing to strengthen its global offering for the chemicals industry?
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
most read
Ratcliffe: Chemical Industry in Europe at a Tipping Point
Ineos CEO Ineos calls on European politicians to save the chemical industry.
Dow to Shut Down Three Upstream European Assets
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
CHEManager International Media Kit 2026
Compelling solutions through strategic partnerships
Merck Acquires Chromatography Business from JSR Life Sciences
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.